575 related articles for article (PubMed ID: 29866879)
21. Inhaled pentamidine for Pneumocystis jiroveci prophylaxis in a heart transplant recipient with allergy for trimethoprim sulfamethoxazole.
Altintas G; Diken AI; Diken OE; Hanedan O; Kucuker SA
Exp Clin Transplant; 2011 Feb; 9(1):72-3. PubMed ID: 21605028
[TBL] [Abstract][Full Text] [Related]
22. Failures of once-a-week trimethoprim-sulfamethoxazole prophylaxis in children undergoing allogeneic hematopoietic stem cell transplant.
Castagnola E; Mesini A; Saffioti C; Moscatelli A; Pierri F; Giardino S; Faraci M
Transpl Infect Dis; 2020 Feb; 22(1):e13231. PubMed ID: 31846143
[TBL] [Abstract][Full Text] [Related]
23. Pneumocystis jirovecii Pneumonia in the Non-HIV-Infected Population.
Avino LJ; Naylor SM; Roecker AM
Ann Pharmacother; 2016 Aug; 50(8):673-9. PubMed ID: 27242349
[TBL] [Abstract][Full Text] [Related]
24. Aerosolized pentamidine as alternative primary prophylaxis against Pneumocystis carinii pneumonia in adult hepatic and renal transplant recipients.
Saukkonen K; Garland R; Koziel H
Chest; 1996 May; 109(5):1250-5. PubMed ID: 8625676
[TBL] [Abstract][Full Text] [Related]
25. Trimethoprim-sulfamethoxazole compared with ciprofloxacin for the prevention of urinary tract infection in renal transplant recipients. A double-blind, randomized controlled trial.
Hibberd PL; Tolkoff-Rubin NE; Doran M; Delvecchio A; Cosimi AB; Delmonico FL; Auchincloss H; Rubin RH
Online J Curr Clin Trials; 1992 Aug; Doc No 15():[4083 words; 46 paragraphs]. PubMed ID: 1343609
[TBL] [Abstract][Full Text] [Related]
26. Successful Pneumocystis carinii pneumonia prophylaxis using aerosolized pentamidine in children with acute leukemia.
Weinthal J; Frost JD; Briones G; Cairo MS
J Clin Oncol; 1994 Jan; 12(1):136-40. PubMed ID: 8270969
[TBL] [Abstract][Full Text] [Related]
27. A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group.
Schneider MM; Hoepelman AI; Eeftinck Schattenkerk JK; Nielsen TL; van der Graaf Y; Frissen JP; van der Ende IM; Kolsters AF; Borleffs JC
N Engl J Med; 1992 Dec; 327(26):1836-41. PubMed ID: 1360145
[TBL] [Abstract][Full Text] [Related]
28. Dapsone safety in hematology patients: Pathways to optimizing Pneumocystis jirovecii pneumonia prophylaxis in hematology malignancy and transplant recipients.
Urbancic KF; Pisasale D; Wight J; Trubiano JA
Transpl Infect Dis; 2018 Dec; 20(6):e12968. PubMed ID: 30030892
[TBL] [Abstract][Full Text] [Related]
29. The use of intravenous pentamidine for the prophylaxis of Pneumocystis pneumonia in pediatric patients.
Kruizinga MD; Bresters D; Smiers FJ; Lankester AC; Bredius RGM
Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28074607
[TBL] [Abstract][Full Text] [Related]
30. Comparison of trimethoprim-sulfamethoxazole and aerosolized pentamidine for primary prophylaxis of Pneumocystis jiroveci pneumonia in immunocompromised patients with connective tissue disease.
Kimura M; Tanaka S; Ishikawa A; Endo H; Hirohata S; Kondo H
Rheumatol Int; 2008 May; 28(7):673-6. PubMed ID: 18080124
[TBL] [Abstract][Full Text] [Related]
31. Utility of inhaled pentamidine prophylaxis in lung transplant recipients.
Nathan SD; Ross DJ; Zakowski P; Kass RM; Koerner SK
Chest; 1994 Feb; 105(2):417-20. PubMed ID: 8306738
[TBL] [Abstract][Full Text] [Related]
32. Twice weekly prophylaxis with trimethoprim/sulfamethoxazole for
Awad M; Sierra CM; Mesghali E; Bahjri K
J Oncol Pharm Pract; 2021 Dec; 27(8):1936-1939. PubMed ID: 33307970
[TBL] [Abstract][Full Text] [Related]
33. Pneumocystis jirovecii pneumonia prophylaxis in allogeneic hematopoietic cell transplant recipients: can we always follow the guidelines?
Redjoul R; Robin C; Foulet F; Leclerc M; Beckerich F; Cabanne L; di Blasi R; Pautas C; Toma A; Botterel F; Maury S; Cordonnier C
Bone Marrow Transplant; 2019 Jul; 54(7):1082-1088. PubMed ID: 30413810
[TBL] [Abstract][Full Text] [Related]
34. Prophylaxis and treatment of Pneumocystis Jirovecii pneumonia after solid organ transplantation.
Brakemeier S; Pfau A; Zukunft B; Budde K; Nickel P
Pharmacol Res; 2018 Aug; 134():61-67. PubMed ID: 29890253
[TBL] [Abstract][Full Text] [Related]
35. Incidence of Pneumocystis jirovecii and Adverse Events Associated With Pneumocystis Prophylaxis in Children Receiving Glucocorticoids.
Basiaga ML; Ross ME; Gerber JS; Ogdie A
J Pediatric Infect Dis Soc; 2018 Dec; 7(4):283-289. PubMed ID: 28992298
[TBL] [Abstract][Full Text] [Related]
36. Aerosolized pentamidine for the prevention of Pneumocystis carinii pneumonia in children with cancer intolerant or allergic to trimethoprim/sulfamethoxazole.
Mustafa MM; Pappo A; Cash J; Winick NJ; Buchanan GR
J Clin Oncol; 1994 Feb; 12(2):258-61. PubMed ID: 8113834
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of pentamidine tolerability and efficacy between
Koon A; He J; Patel J; Morse A; Boseman V; Hamilton A; Knight T; Shah N; Ragon B; Chojecki A; Ai J; Steuerwald N; Gerber J; Copelan E; Grunwald M; Arnall J
Pharmacogenomics; 2023 Oct; 24(15):821-830. PubMed ID: 37846549
[TBL] [Abstract][Full Text] [Related]
38. Trimethoprim-sulphamethoxazole appears more effective than aerosolized pentamidine as secondary prophylaxis against Pneumocystis carinii pneumonia in patients with AIDS.
Carr A; Tindall B; Penny R; Cooper DA
AIDS; 1992 Feb; 6(2):165-71. PubMed ID: 1558714
[TBL] [Abstract][Full Text] [Related]
39. Cost and benefit of secondary prophylaxis for Pneumocystis carinii pneumonia.
Castellano AR; Nettleman MD
JAMA; 1991 Aug; 266(6):820-4. PubMed ID: 1907671
[TBL] [Abstract][Full Text] [Related]
40. Treatment of Pneumocystis jirovecii pneumonia in HIV-infected patients: a review.
Huang YS; Yang JJ; Lee NY; Chen GJ; Ko WC; Sun HY; Hung CC
Expert Rev Anti Infect Ther; 2017 Sep; 15(9):873-892. PubMed ID: 28782390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
